gene therapy - search results

Prof Dr Chris Meier at the University of Hamburg, Faculty of Sciences, Department of Chemistry explores antiviral and antitumor therapies. He discusses the intracellular delivery of antivirally active nucleoside triphosphates and argues that the ultimate challenge is applying these as chemotherapeutics

A report this week from the Office of Health Economics (OHE) shows the amazing impact medicines have had on the NHS and more widely

Data from Public Health England shows that cancer diagnosis could impact upon which kind of treatment a patient receives.

World’s second largest inter-governmental body and First Ladies from 16 African Nations deliver Africa cancer awareness event with and agree measures to combat the spread of cancer in Africa

Dr Eleanor D Kennedy, Research Manager at the Diabetes Research and Wellness Foundation explains why diabetes is a global epidemic and at the same time, a local problem

Members of the RELEVANCE consortium – Anna Bogdanova, Francesca Aglialoro, Marieke von Lindern, Emile van Akker, Ashley Toye, and Pedro Moura – explain their thoughts on erythropoiesis, in and out of the body.

Prof Dr Freimut Schliess, Director of Science & Innovation at Profil Institut für Stoffwechselforschung GmbH explains the important role of innovation when it comes to healthy living and active ageing, including his thoughts on the diabetes paradigm

The European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) give a detailed perspective on environmental toxicology, a life science discipline that seeks to understand how chemicals, both natural and man-made, can interact with environmental species and human physiology to cause harm

Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on the world of nanomedicines, with a special focus on depicting human health risks hindering clinical translation.

Dr Martin English, Consultant Paediatric Oncologist and member of the Royal College of Paediatrics and Child Health (RCPCH) explains the challenge of curing cancer in the world’s children

Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores how outcomes for acute myeloid leukaemia (AML) can be improved

Michael Roth, Research group leader at the University & University Hospital Basel explores the current state of chronic inflammatory lung diseases, from the molecular biology perspective

Can we prevent the muscle loss associated with some cancers? Dr Vera Mazurak at the University of Alberta is looking into one method of treating myosteatosis Pathological fat infiltration into muscle is a feature of disease-induced muscle loss that significantly associates with shorter survival in people with cancer. Fat is...

Paul De Raeve, Secretary General and Elisabeth Adams, President of the European Federation of Nurses Associations (EFN) tell us why the European Pillar of Social Rights should help nurses to remain in the nursing profession

Simone Boselli, Public Affairs Director of EURORDIS shares the fascinating findings of a new position paper that offers a synthesis of their analysis, reflections and perspectives on access to rare disease therapies in Europe today

The role of advanced technologies in healthcare, including the work of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in this area, is placed under the spotlight by Open Access Government

A change of paradigm improves patients’ outcomes with diabetes & peripheral arterial disease, according to the Division of Angiology at the Medical University of Vienna

The work of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training in the United States, is profiled here by Open Access Government

Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.

The current state of metabolomics research and application in Acute Myeloid Leukaemia is placed under the spotlight by Bradley Stockard and Jatinder Lamba from Department of Pharmacotherapy and Translational Research, University of Florida